Abstract-In this work, we present results produced from a nonlinear QSAR model developed and implemented using evolutionary computation and Random Forest Regression to study the effectiveness of dimeric Aryl ȕ-Diketo Acids on HIV-1 Integrase enzyme inhibition. Dimeric Aryl ȕ-Diketo Acids have been proven to be effective inhibitors of the biological mechanism of protein transfer known as HIV-integrase. This research extends a previous study of Aryl ȕ-Diketo Acids for HIV-1 Integrase inhibition [1] that used linear QSAR models implemented using a Multiple Linear Regression (MLR) machine learning strategy and a hybridized Differential Evolution-Binary Particle Swarm Optimization (DE-BPSO) algorithm to select and identify, respectively, drug descriptors having the greatest inhibitory effect on HIV-1 Integrase. This comparative study uses a non-linear Random Forest Regression (RFR) strategy with adaptive boosting (AdaBoost) to generate QSAR models with greater predictive qualities in identifying optimal drug feature descriptors that can more effectively inhibit HIV protein enzyme activity.
I. INTRODUCTION
The human immunodeficiency virus type 1 (HIV-l) is a retrovirus responsible for triggering the acquired immunodeficiency syndrome (AIDS) disease. According to estimates by the World Health Organization (WHO), 35.3 million people were living with HIV at the end of 2012. That same year, some 2.3 million people became newly infected, and 1.6 million died of AIDS-related causes [2] . As of 2015, exactly 25 pharmaceutical drug compounds have been approved for clinical use in the U.S. [3] . Most of these compounds affect reverse transcriptase and protease, two enzymes that play a vital role in the replication cycle of HIV-1. Different combinations of compounds targeting these enzymes are created, tested and prescribed as a drug cocktail to affected patients. Crystallization of these enzyme's binding mechanism provides a way of inhibiting additional reproductive activity of the virus. Although inhibitor treatments targeting the reverse transcriptease and protease enzymes have been developed, the crystal structure of the integrase enzyme is less understood. Insight into these structures would allow researchers to determine how drug resistance affects the binding mechanism of different inhibitors. [23] The challenge for current pharmacological research lies primarily in developing more effective compounds as the HIV-1 virus genome continues to mutate and evolve to develop resistance to current forms of anti-HIV-1 inhibitory treatments. QSAR models provide a way of understanding each drug molecule's binding mechanism in terms of its physiochemical properties, as well as corresponding inhibitor-virus protein interactions.
Dimeric Aryl ߚ-Diketo acids represent a particularly potent class of chemical molecules known to be effective inhibitors of the protein strand transfer mechanism of HIV-1 integrase, combinations of these chemical molecules are prescribed as a drug cocktail called highly active anti-retroviral therapy (HAART). Mutations in the HIV-1 retrovirus, however, trigger a natural growth to resistance to current HIV-I inhibitors which motivate the need for further research and design of new anti-HIV-1 drug treatments [1] [17] .
II. BACKGROUND
Machine learning and data mining are at the heart of the medical research community's efforts at computer aided drug design, of which Quantitative Structure-Activity Relationship (QSAR) modelling plays a critical role. The study of QSAR was pioneered in the early 1960s when it was found that the biological activity of a chemical compound can be defined as a function of its physiochemical properties. These properties are derived from chemical compound structures which are mapped to the target biological activity as part of the QSAR modelling process. The results of this mapping are quantified by a statistically measureable value that can be used as a basis for correlating the physiochemical properties to the desired target biological activity. Examples of physiochemical properties include solvent accessible areas, total energy, dipole moment and molecular weight, among others. Over the years a variety of standard QSAR properties have been derived for use in modelling and analyzing additional chemical within the pharmaceutical research community [14] . 
A. Model Development
In our research, a non-linear approach has been implemented with a focus on identifying drug descriptors contributing most to the inhibition of HIV-1 Integrase by training an AdaBoost [5] Random Forest Regressor to fit feature descriptors selected by DE-BPSO to a set of pIC50 regression targets to come up with a more effective model for predicting the molecular structure of potentially more novel and effective inhibitory drug treatments. The results produced from simulations of our non-linear Random Forest model are compared to those of the linear model developed in a previous QSAR study [1] .
B. Non-Linear QSAR Models
For this effort, a hybridized Differential Evolution and Binary Particle Swarm Optimization (DE-BPSO) evolutionary computation strategy was used to select optimal feature descriptors for training an AdaBoost RF [1] . Through a variety of benchmark optimization problems, DE was found to outperform standalone PSO, while at the same time providing more robust and consistent results over continuous simulations [16] . Binary Particle Swarm Optimization (BPSO) was proposed as an implementation of PSO designed to solve discretized problems, with dimensions of each particle's position being represented by a 0 or 1, [12] [21] . A hybridized approach that leverages DE has been shown to effectively improve BPSO, which like PSO, is traditionally more sensitive to its parameters and much more dependent on random initialization of the particles in the swarm, the DE mutation and cross-over strategies are used to evolve the velocity vectors for updating the positions of each particle in each iteration of the swarm; this causes the search space to be explored by each individual particle with greater efficiency [1] .
III. METHODS
Training a non-linear QSAR model involves operations of feature selection and model training. Data is first processed by hybridized DE-BPSO, which performs feature selection on the drug descriptor dataset. The idea is that we apply DE mutation and cross-over on particle velocities and use them to update each particle's position in the search space. Each position models the selected drug descriptors to be trained by the AdaBoost Random Forest. In this study we implemented a nonlinear AdaBoost Random Forest algorithm using Python SciKits-Learn open-source machine learning library [8] . Each particle in the DE-BPSO swarm population is a single drug sample from the dataset.
Feature selection begins by initializing the velocity and position of each particle ‫ݒ‬ ൌ ‫݀݊ܽݎ‬ሺͲǡͳሻ (1)
where ߣ is a parameter controlling the probability of selecting a descriptor. To minimize the total number of descriptors selected by each particle, we configure the value with ߣ ൌ ͲǤͲͳ [1] . The local best position ‫(‬ ሻ and global best positions ‫(‬ ሻ are tracked in each iteration. DE updates each swarm particle's velocity via the mutation rules defined in Eq.3 which creates a provisional velocity from three mutually distinct particles selected from the swarm.
Here ‫ݒ‬ ǡ ‫ݒ‬ ǡ ‫ݒ‬ are velocities of the three mutually distinct particles and ‫ܨ‬ is a scaling factor that controls the length and amplification of the differential variation of the exploration vector ሺ‫ݒ‬ െ ‫ݒ‬ ሻ [13] . DE cross-over is applied according to the rules in Eq. 4 to obtain the final updated velocity, where CR is a constant representing the evolutionary cross-over rate. The value of CR is 0.7 as defined in a previous linear MLR QSAR study [1] . The updated velocity is used to determine the new position of the particle for the next iteration according the following rules
The ߚ parameter is a bit mutation value controlling the probability of flipping a positional bit; this study used a ߚ setting of 0.004 which was determined through experimentation to be the optimal value for DE-BPSO feature selection [1] . The ߙ parameter is a static probability that controls the balance of local and global searching among the swarm. Larger values of ߙ would allow the particles to overcome local optima, whereas a smaller ߙ would cause it to converge towards the prior iteration's local and global best positions. The implementation by Shen et al. was designed such that the particles search the global solution space at the start of the swarm iteration and on a local scale towards the end, ߙ was initially set to 0.5 and gradually decreases down to 0.33 by the termination generation [12] . Features selected by DE-BPSO are used by the AdaBoost RF learner to train a non-linear predictive QSAR model. The model is used to compute the predicted pIC50 values ሺ‫ݕ‬ ො ሻ for this iteration. The predictions are used to compute the fitness value of each particle in the swarm for the next iteration using the fitness and RMSE formulas in Eq. 6 and Eq. 7, respectively.
Where ݉ ௧ ǡ ݉ ௩ are the total samples in the training and validation sets respectively, ݊ is the total number of drug feature descriptors, ‫ܧܵܯܴ‬ is the root-mean-square error of the predicted pIC50 values for the train and validation sets and ߛ is a parsimonious penalty value that supports controlling the balance between models that over-fit and under-fit. From the previous linear QSAR model study on this dataset, ߛ ൌ ͵Ǥ͵ was determined to be the optimal value to use for evaluating model fitness [1] [20]. After each particle's fitness in is calculated, we end training if the fitness has not changed in 30 iterations or if we've reached a maximum of 2000 iterations. Otherwise, we check if the swarm's local best position is better than the current global best, if it is we update the global best position to be the best of local best positions of all local bests that have been created so far.
C. Validating a QSAR model
It's not enough for a generated model to fit to data it's trained on, it must be statistically validated to ensure predictive reliability, in the absence of any kind of statistical quality measures a model may fail future validation tests and could not be used as a practical drug screening utility. [6] .
IV. MODELS
Random forests are an ensemble machine learning technique for regression tasks that use multiple decision tree learners (i.e. an ensemble) to collectively predict the value of a target observation, with the output being the average of the prediction of each individual DT in the forest. This behavior allows Random Forests to compensate for each individual DT's tendency to over-fit to the training set. Each decision tree in our model takes input in the form of ሺܺǡ ܻሻ, where ܻ is the target vector and ܺ is the input vector of feature descriptors, selected by DE-BPSO. Using this information, each decision tree regression model acts as an individual meta-estimator that casts a vote for the predicted target observation, the random forest then averages the predicted value from the votes cast by each tree within the ensemble [4] . When growing, each tree considers a random sample from variables of the given input vector ܺ at each nodal split. Sample data at each node is represented as Q, an impurity measure is used as the criterion to determine the variable to be selected at eachh nodal split. ) as the impurity criteria ‫ݔ‪ሺ‬ܪ‬ ሻ. The selected feature ‫ݔ‬ at each nodal split is the descriptor that minimizes this impurity. To predict the continuous pIC50 target value, the problem space is partitioned so samples that minimize this impurity are grouped together. A meta-estimator strategy called AdaBoost provides additional support to the random forest regression model over each training iteration, where idea is to sequentially train copies of a Random Forest on a data set. Using a sequential optimization strategy, a Random Forest copy is dynamically adjusted to focus fitting on values that were incorrectly predicted by a copy in the previous stage of a boost sequence [9] . This process has the intuitive effect of forcing each subsequent Random Forest copy to focus on more difficult cases [5] . This approach helped mitigate the effects of over-fitting on the Aryl ߚ-Diketo acid drug dataset and resulted in improved convergence toward an optimal QSAR model.
V. RESULTS
We now discuss and compare results from models having the best predictive qualities obtained from two simulations of DE-BPSO and Random Forest with Adaptive Boosting.
A. Experiment Datasets and Parameters
The sets of 37 and 91 dimeric Aryl ȕ-Diketo Acids under analysis were derived through experimental inhibitory activities and found to be capable of effectively inhibiting HIV-1 integrase protein strand transfer function crucial to the virus' reproductive cycle. Each dataset consisted of 396, and 385 constitutional, geometrical, topological, electrostatic and quantum-chemical descriptors, respectively [1] . The KennardStone algorithm [10] was used to partition each dataset into training, validation and test subsets with ݊ ௧ ൌ ʹ͵, ݊ ௩ௗ௧ ൌ and ݊ ௧௦௧ ൌ compounds for the 37 drugs and ݊ ௧ ൌ ͵, ݊ ௩ௗ௧ ൌ ͳͶ and ݊ ௧௦௧ ൌ ͳͶ compounds for 91 drugs. This method provides a uniform distribution of descriptors to help ensure all biological activities are properly tested. The regression targets for each dataset represent a sample's pIC50=-log(IC50) value which is a measure of the Aryl ȕ-Diketo Acid compound concentration required to achieve 50% or more biological activity inhibition. Note that the ‫Ͳ‪ͷ‬ܥܫ‬ is taken as the negated log unit of the ‫Ͳ‪ͷ‬ܥܫ‬ value, so higher values will typically indicate exponentially greater potency. A common cut-off for defining potent compounds is a ‫Ͳ‪ͷ‬ܥܫ‬ [11] . Simulations for each dataset completed 2000 iterations of training a Random Forest with Adaptive Boosting on features selected by 50 particles making up the DE-BPSO swarm population; the total number of decision tree estimators of the Random Forest was set to 50 to match the size of the swarm population. The parameters for each model were tuned to be consistent to better compare with a previous linear MLR QSAR study [1] . Parameters ߚ ൌ ͲǤͲͲͶ, a scaling factor ‫ܨ‬ ൌ ͲǤ and a cross-over rate of ‫ܴܥ‬ ൌ ͲǤ were found to produce the most predictive linear MLR QSAR model and were used to train the non-linear AdaBoost Random Forest model on the set of 37 and 91 dimeric Aryl ȕ-Diketo Acids.
B. Comparison of Non-Linear and Linear QSAR models
Initial results were very promising, the model with the best predictive and correlative qualities generated by our non-linear AdaBoost Random Forest implementation is compared to previous linear DE-BPSO MLR predictive results and shows a significant improvement for the 37 drug dataset [1] [22] . Although predictive scores for the 91 drug descriptors were not as high as the linear MLR-based QSAR model, they still meet the minimum requirement to be considered reliable for further analysis [6] [7] . The non-linear model presents much better predictive qualities on the 37 drug data set, this suggest a non-linear AdaBoost RF QSAR model could find a more accurate correlation of between selected descriptors and the target inhibitory response quantified by the experimental pIC50 dataset. From the results produced from the non-linear AdaBoost RF model, we see the number of aromatic bonds, a minimum electrophilic reaction index for C atoms and an average electrophilic reaction index for O atoms are molecular descriptors with the most influence on the biological inhibitory activities of Aryl ȕ-Diketo Acids. As previously described, the linear MLR was able to perform better on the 91 drug data set, with similar training parameters. In each of the 37 and 91 drug sample simulations, the total number of individual decision tree estimators in the non-linear AdaBoost Random Forest QSAR model was set to be equal to the number of particles in the binary swarm population, since the non-linear RF model was able to outperform the linear MLR model on the smaller 37 drug dataset, an AdaBoost Random Forest tuned with a larger ensemble of estimators may be able to perform better on larger datasets than the linear MLR model. In this study, we implemented a DE-BPSO feature selection algorithm and AdaBoost Random Forest Regression learner to develop a non-linear QSAR model for the analysis of Aryl ȕ-Diketo Acids targeting the inhibition of HIV-1 integrase protein enzyme by identifying the physiochemical molecular descriptors that exhibit the greatest influence on the crystallization of the integrase enzyme's binding mechanism. An experiment was run on two sets of 37 and 91 dimeric Aryl ȕ-Diketo Acids partitioned into a training, validation and test sets. Results found descriptors with the greatest inhibitory effect on the biological activity of ȕ-diketo acids are those related to molecular volume, topology, and electrostatic effects, with large molecular volumes having the greatest impact.
For the 37 drug data set, the number of aromatic bonds, a minimum electrophoresis reaction index for C atoms and an average electrophoresis reaction index for O atoms were found to be the most significant features of molecules having the most effective toward HIV-1 integrase inhibition. The quality measures and correlation were better than those produced from a previous linear MLR QSAR model [1] . The results are also very encouraging since the HIV-1 integrase active site is considered to be hydrophobic in nature with a single ‫ܩܯ‬ ଶା ion available for chelation with a drug compound for enzymatic inhibition [19] . For the 91 drug data set, the relative number of benzene rings, Kier & Hall index (order 2) and HA dependent HDCA-2/SQRT (TMSA) [Zefirov's PC] were considered to be the most significant descriptors. Although predictive scores were lower compared to the linear MLR QSAR model, the resulting non-linear AdaBoost RF was still able to produce a model fitting the minimum requirements for predictive quality.
